# Intrathecal Dexmedetomidine 5 mcg Versus 10 mcg With Bupivacaine for Infra-umbilical Surgery

Study · id `cardio:ct-nct07929818` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07929818](<https://clinicaltrials.gov/study/NCT07929818>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07929818

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 544 participants.

## Technical summary

Registry record NCT07929818. Randomized; single masking; primary purpose treatment. Start 2025-08-01 (actual); primary completion 2026-10-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 544 participants (enrolled count; ClinicalTrials.gov record NCT07929818, source copy `cardio:ctgov-nct07929818-2026-11-10`, retrieved 2026-11-18)
- Started: 2025-08-01 (actual) (ClinicalTrials.gov record NCT07929818, source copy `cardio:ctgov-nct07929818-2026-11-10`, retrieved 2026-11-18)
- Primary completion: 2026-10-31 (actual) (ClinicalTrials.gov record NCT07929818, source copy `cardio:ctgov-nct07929818-2026-11-10`, retrieved 2026-11-18)
- Completion: 2026-10-31 (actual) (ClinicalTrials.gov record NCT07929818, source copy `cardio:ctgov-nct07929818-2026-11-10`, retrieved 2026-11-18)
- Countries: Pakistan (ClinicalTrials.gov record NCT07929818, source copy `cardio:ctgov-nct07929818-2026-11-10`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07929818-2026-11-10`, retrieved 2026-11-18)

## The registry's words

- Brief title: Intrathecal Dexmedetomidine 5 mcg Versus 10 mcg With Bupivacaine for Infra-umbilical Surgery
- Condition: Spinal Anesthesia
- Condition: Intraoperative Hypotension
- Condition: Bradycardia
- Intervention (Drug): Dexmedetomidine 5 micrograms (intrathecal)
- Intervention (Drug): Dexmedetomidine 10 micrograms (intrathecal)
- Intervention (Drug): Hyperbaric bupivacaine 0.5%
- Lead sponsor: Hussain Aziz Bhatti
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Bradycardia (`cardio:bradycardia`)

## Provenance

Content hash: 7ec39522bcd9b018b7ccc9bcd40bf83165052ef3f9e43808d6c6683658604134
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
